Cite
HARVARD Citation
Ossenkoppele, G. et al. (n.d.). A phase I first‐in‐human study with tefinostat – a monocyte/macrophage targeted histone deacetylase inhibitor – in patients with advanced haematological malignancies. British journal of haematology. pp. 191-201. [Online].